WebNov 8, 2024 · DiagnaMed Holdings Corp. (CSE: DMED) is an artificial intelligence driven digital diagnostics and therapeutics company focusing on improving brain health for … WebApr 11, 2024 · TORONTO, April 11, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a digital health AI company, is pleased to announce that effective April 11, 2024, the Company is listed on the OTCQB Venture Market (“OTCQB”) under the symbol “DGNMF”. The Company will …

DiagnaMed Holdings to Commercialize Virtual Reality Tech That …

WebFeb 1, 2024 · DiagnaMed Holdings Corp. (CSE: DMED) is an artificial intelligence-driven digital health company focusing on improving brain health for mental health and neurodegenerative disorders. WebInVesta Services maintains an extensive database of tax liens and deeds relating to InVesta Services and its affiliates’ portfolios. Banks, mortgage-servicing companies, closing … fitzroy crossing visitor centre wa

Diagnamed Holdings Corp. (DMED.CN) Stock Price, News, Quote …

WebSign up for latest press releases. Email Address Subscribe. × WebDiagnaMed Announces Application for OTCQB Listing. Increasing awareness within the U.S. capital markets DiagnaMed focused on commercializing CERVAI™, its proprietary Brain Health AI Platform leveraging Generative AI TORONTO, March 09, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: … WebFeb 13, 2024 · TORONTO, Feb. 13, 2024 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (), a digital health generative AI company, announced today that Ms. Emily Davis resigned as director of the Board of Directors (the “Board”) and is replaced by the appointment of Mr. Carlo Sansalone to the Board as … fitzroy crossing visitors centre